Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May 1;27(9):2369-2371.
doi: 10.1158/1078-0432.CCR-21-0085. Epub 2021 Feb 18.

Eligibility in Cancer Clinical Research: The Intersection of Discovery, Generalizability, Beneficence, and Justice

Bruce J Giantonio  1
Affiliations
Comment

Eligibility in Cancer Clinical Research: The Intersection of Discovery, Generalizability, Beneficence, and Justice

Bruce J Giantonio. Clin Cancer Res. .

Abstract

Eligibility criteria in clinical trials limit the study population for safety and scientific purposes. The American Society of Clinical Oncology and The Friends of Cancer Research collaboration reconsidered common eligibility criteria in cancer trials and found many to be unnecessarily restrictive. The current recommendations further their efforts to facilitate accrual and improve the generalizability of research results to practice.See related articles, p. 2394, 2400, 2408, 2416, 2424, and 2430.

PubMed Disclaimer

Comment on

References

    1. Kim ES, Uldrick TS, Schenkel C, Bruinooge SS, Harvey RD, Magnuson A, et al. Continuing to broaden eligibility criteria to make clinical trials more representative and inclusive: ASCO-Friends of Cancer Research joint research statement. Clin Cancer Res. 2021;27:2394–9.
    1. Harvey RD, Bruinooge SS, Chen L, Garrett-Mayer E, Rhodes W, Stepanski E, et al. Impact of broadening trial eligibility criteria for patients with advanced non-small cell lung cancer: real-world analysis of select ASCO-Friends recommendations. Clin Cancer Res. 2021;27:2430–4.
    1. Spira AI, Stewart MD, Jones S, Chang E, Fielding A, Richie N, et al. Modernizing clinical trial eligibility criteria: recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group. Clin Cancer Res. 2021;27:2416–23.
    1. Harvey RD, Mileham KF, Bhatnagar V, Brewer J, Rahman A, Moravek C, et al. Modernizing clinical trial eligibility criteria: recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work Group. Clin Cancer Res. 2021;27:2400–7.
    1. Osarogiagbon RU, Merino Vega D, Fashoyin-Aje L, Wedam S, Ison G, Atienza S, et al. Modernizing clinical trial eligibility criteria: recommendations of the ASCO-Friends of Cancer Research Prior Therapies Work Group. Clin Cancer Res. 2021;27:2408–15.

LinkOut - more resources